Review Article The immunology and immunotherapy of breast cancer: an update
- 8 March 1999
- journal article
- review article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 21 (2) , 79-101
- https://doi.org/10.1016/s0192-0561(98)00077-0
Abstract
No abstract availableKeywords
This publication has 130 references indexed in Scilit:
- The correlation of CA15.3 and TPS with tumor course in patients with metastatic breast cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- Active immunotherapy with transiently transfected cytokine-secreting tumor cells inhibits breast cancer metastases in tumor-bearing animalsSurgery, 1996
- Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumoursEuropean Journal Of Cancer, 1996
- Tissue polypeptide specific antigen (TPS) in breast cancer—an initial evaluationEuropean Journal of Surgical Oncology, 1996
- Strategies for the development of recombinant vaccines for the immunotherapy of breast cancerBreast Cancer Research and Treatment, 1996
- The Immunology of Breast CancerClinical Immunotherapeutics, 1995
- T-cell adjuvantsInternational Journal of Immunopharmacology, 1994
- Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvantCancer Immunology, Immunotherapy, 1993
- Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: Effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 geneCancer Immunology, Immunotherapy, 1993
- Lymphocyte infiltrates as a prognostic variable in female breast cancerEuropean Journal Of Cancer, 1992